KIMBERLY SMITH: Open Payments
NPI 1124791108 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 22 payments from 8 companies in 2025. Trend: 2023 $851 · 2024 $367 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $129 |
| Janssen Pharmaceuticals, Inc | 4 | $112 |
| Vanda Pharmaceuticals Inc. | 1 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, FANAPT, INVEGA SUSTENNA, ABILIFY MAINTENA, TRINTELLIX, ABILIFY ASIMTUFII, Auvelity.
Industry payments across CO — which companies pay providers there.
